The drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.

by Laura Gesualdi-Gilmore

Scientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to fight the disease.

by Thomas Celona

The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.

by Sandra Gordon

Immunotherapy has helped some young people with alveolar soft part sarcoma (ASPS), a rare cancer, but there’s more work to be done.

by Kyle Bagenstose

The FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?

by Sandra Gordon

Immunotherapy before surgery is proving to be an effective treatment against melanoma.

by Sandra Gordon

Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

by Laurie Adami

At a patient advocate event, researchers discussed how to extend the benefits of immunotherapy to more people.

by Kevin McLaughlin

For people with melanoma who receive immune checkpoint inhibitors after surgery, side effects can remain even after treatment has been completed. These chronic side effects are most often mild.

by Anna Goshua

In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs?

by Anna Goshua